Literature DB >> 11181908

Titer-dependent antagonism of cocaine following active immunization in rhesus monkeys.

L Koetzner1, S Deng, T L Sumpter, M Weisslitz, R T Abner, D W Landry, J H Woods.   

Abstract

Immunization may be a useful pharmacokinetic antagonist therapy for cocaine users. Three rhesus monkeys were immunized with a cocaine:bovine serum albumin conjugate in alum and later with complete and incomplete Freund's adjuvants. Monkeys developed cocaine-binding antibodies (as measured by enzyme-linked immunosorbent assay) after immunization with alum; greater antibody titers developed after immunization with Freund's adjuvants. The response rate-decreasing effect of cocaine diminished in proportion to antibody titer; there was no substantial change in the rate-decreasing effect of bupropion. Plasma cocaine concentrations increased in proportion to antibody titer. Immunizations were well tolerated and had no effect on response rates. These data suggest that the antibody response to a cocaine antigen can produce a specific pharmacokinetic shift in cocaine distribution sufficient to antagonize a behavioral effect of the drug, and can do so with minimal side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181908

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.

Authors:  Ashley L St John; Hae Woong Choi; Q David Walker; Bruce Blough; Cynthia M Kuhn; Soman N Abraham; Herman F Staats
Journal:  NPJ Vaccines       Date:  2020-02-05       Impact factor: 7.344

Review 2.  Anti-cocaine vaccine development.

Authors:  Berma M Kinsey; Thomas R Kosten; Frank M Orson
Journal:  Expert Rev Vaccines       Date:  2010-09       Impact factor: 5.217

3.  Pre-clinical safety and toxicology profile of a candidate vaccine to treat oxycodone use disorder.

Authors:  Fatima A Hamid; Cheryl L Marker; Michael D Raleigh; Aaron Khaimraj; Scott Winston; Paul R Pentel; Marco Pravetoni
Journal:  Vaccine       Date:  2022-04-22       Impact factor: 4.169

Review 4.  Development of active and passive human vaccines to treat methamphetamine addiction.

Authors:  W Brooks Gentry; Daniela Rüedi-Bettschen; S Michael Owens
Journal:  Hum Vaccin       Date:  2009-04-20

5.  The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats.

Authors:  Andrew B Norman; Mantana K Norman; William R Buesing; Michael R Tabet; Vladimir L Tsibulsky; William J Ball
Journal:  J Pharmacol Exp Ther       Date:  2008-12-16       Impact factor: 4.030

6.  Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans.

Authors:  Margaret Haney; Erik W Gunderson; Huiping Jiang; Eric D Collins; Richard W Foltin
Journal:  Biol Psychiatry       Date:  2010-01-01       Impact factor: 13.382

7.  Design of cocaethylene and cocaine conjugates to produce highly selective polyclonal antibodies.

Authors:  Caroline Gadjou; Yannic Danger; Pierre Sandouk; Jean-Michel Scherrmann; Dominique Blanchard; Gilles Folléa; Hervé Galons
Journal:  Int J Biomed Sci       Date:  2006-02

8.  Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy.

Authors:  Ashley L St John; Hae Woong Choi; Q David Walker; Bruce Blough; Cynthia M Kuhn; Soman N Abraham; Herman F Staats
Journal:  NPJ Vaccines       Date:  2020-02-05       Impact factor: 7.344

Review 9.  Progress towards achieving new vaccine and vaccination goals.

Authors:  G Ada
Journal:  Intern Med J       Date:  2003-07       Impact factor: 2.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.